A Service For Professionals Tuesday, October 17, 2017
Contact (202) 540-8337
Company News Today
A Service For Professionals Tuesday, October 17, 2017 11614 Sources 410,242,902 Articles 3,134,516 Readers
Contact (202) 540-8337

Webcast Wire: ADVENTRX Pharmaceuticals

December 16, 2009 (FinancialWire) (Investrend Broadcast Syndicate) — ADVENTRX Pharmaceuticals, Inc. (AMEX: ANX) webcast their Lippert/Heilshorn Life Sciences Conference presentation yesterday. A recording and podcast version of that presentation is now available (via http://infoescrow.net/f/?u=http://www.investorcalendar.com/IC/ClientPage.asp?ID=153278).

ADVENTRX Pharmaceuticals, Inc., a biopharmaceutical company, focuses on in-licensing, developing, and commercializing proprietary product candidates for the treatment of cancer. Its lead product candidates include ANX-530, a novel emulsion formulation of chemotherapy drug vinorelbine to treat advanced non-small cell lung cancer as a single agent or in combination with cisplatin, as well as to treat advanced or metastatic breast cancer; and ANX-514, a novel emulsion formulation of the chemotherapy drug docetaxel for the treatment of breast, non-small cell lung, prostate, gastric, and head and neck cancers. The company was founded in 1995 is based in San Diego, California.

The company’s current market capitalization is approximately US$ 23.1 million. ANX’s stock last closed at US$ 0.15 per share.

Other recently webcast company presentations, financial results & earnings calls now available through VCall/WILink include LocatePLUS Holdings, Inc. (OTC: LPHC), Rentech, Inc. (AMEX: RTK), CytRx Corp. (NASDAQ: CYTR) and Santarus, Inc. (NASDAQ: SNTS). Recordings are accessible via the search function at http://infoescrow.net/f/?u=http://www.investorcalendar.com by entering any company’s ticker symbol into the search field.

Recently issued annual reports and company filings available through WILink (http://investrend.ar.wilink.com/?level=279) include Niusule Biotech Corp. (OTCBB: NIUS), JPMorgan European Investment Trust PLC (LSE: JFF), Ecofin Water & Power Opportunities PLC (LSE: ECWO), Invesco Property Income Trust Ltd. (LSE: IPI), Hansa Trust PLC (LSE: HAN) (OTC: FSBTF), Perpetual Income & Growth Investment Trust PLC (LSE: PLI), New India Investment Trust PLC (LSE: NII), JPMorgan Fleming Smaller Japanese Companies Investment Trust PLC (LSE: JPS), Edinburgh Investment Trust PLC (LSE: EDIN) (OTC: EHITF) and Armour Group PLC (LSE: AMR).

(Source for company description: ADVENTRX Pharmaceuticals, Inc.)

FinancialWire(tm) provides complete, daily conference call schedules as a service to shareholders and investors via the FirstAlert(tm) Network’s “Daily FirstAlert(tm)” (http://www.financialwire.net/news-alerts/).

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php).  Contact FinancialWire(tm) directly via inquiries@financialwire.net.

[wreiq] [wbcstsc] [wilnknli]

Powered by EIN Presswire